189 related articles for article (PubMed ID: 2522693)
1. Ewing's sarcoma. A retrospective study of histological and immunohistochemical factors and their relation to prognosis.
Daugaard S; Kamby C; Sunde LM; Myhre-Jensen O; Schiødt T
Virchows Arch A Pathol Anat Histopathol; 1989; 414(3):243-51. PubMed ID: 2522693
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
Fellinger EJ; Garin-Chesa P; Glasser DB; Huvos AG; Rettig WJ
Am J Surg Pathol; 1992 Aug; 16(8):746-55. PubMed ID: 1497115
[TBL] [Abstract][Full Text] [Related]
3. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Devaney K; Vinh TN; Sweet DE
Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
[TBL] [Abstract][Full Text] [Related]
4. The immunophenotype of Ewing's sarcoma. An immunohistochemical analysis.
Dierick AM; Roels H; Langlois M
Pathol Res Pract; 1993 Feb; 189(1):26-32. PubMed ID: 8516214
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of neuron-specific enolase and Leu 7 in Ewing's sarcoma of bone.
Pinto A; Grant LH; Hayes FA; Schell MJ; Parham DM
Cancer; 1989 Sep; 64(6):1266-73. PubMed ID: 2670185
[TBL] [Abstract][Full Text] [Related]
6. [Malignant peripheral neuroectodermal tumors. Histological and immunohistological conditions in 41 cases].
Schmidt D; Harms D; Jürgens H
Zentralbl Allg Pathol; 1989; 135(3):257-68. PubMed ID: 2672676
[TBL] [Abstract][Full Text] [Related]
7. Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior.
Parham DM; Hijazi Y; Steinberg SM; Meyer WH; Horowitz M; Tzen CY; Wexler LH; Tsokos M
Hum Pathol; 1999 Aug; 30(8):911-8. PubMed ID: 10452503
[TBL] [Abstract][Full Text] [Related]
8. Peripheral primitive neuroectodermal tumour and extra-osseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study.
Brinkhuis M; Wijnaendts LC; van der Linden JC; van Unnik AJ; Voûte PA; Baak JP; Meijer CJ
Virchows Arch; 1995; 425(6):611-6. PubMed ID: 7697218
[TBL] [Abstract][Full Text] [Related]
9. Atypical primitive neuroectodermal tumors. Comparative light and electron microscopic and immunohistochemical studies on peripheral neuroepitheliomas and Ewing's sarcomas.
Hasegawa T; Hirose T; Kudo E; Hizawa K; Yamawaki S; Ishii S
Acta Pathol Jpn; 1991 Jun; 41(6):444-54. PubMed ID: 1659113
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological study of Ewing's sarcoma and primitive neuroectodermal tumor].
Kitagawa Y
Nihon Seikeigeka Gakkai Zasshi; 1993 Dec; 67(12):1140-50. PubMed ID: 8308411
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm. The relationship to Ewing's sarcoma in bone and soft tissue.
Kawaguchi K; Koike M
Am J Clin Pathol; 1986 Jul; 86(1):79-83. PubMed ID: 3088982
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children.
Carter RL; al-Sams SZ; Corbett RP; Clinton S
Histopathology; 1990 May; 16(5):461-7. PubMed ID: 2163356
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody MB2: a potential marker for Ewing's sarcoma and primitive neuroectodermal tumor.
Kahn HJ; Thorner PS
Pediatr Pathol; 1989; 9(2):153-62. PubMed ID: 2546133
[TBL] [Abstract][Full Text] [Related]
14. Malignant peripheral neuroectodermal tumours of childhood and adolescence.
Schmidt D; Harms D; Burdach S
Virchows Arch A Pathol Anat Histopathol; 1985; 406(3):351-65. PubMed ID: 3923710
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation.
Moll R; Lee I; Gould VE; Berndt R; Roessner A; Franke WW
Am J Pathol; 1987 May; 127(2):288-304. PubMed ID: 2437802
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological study of Ewing's sarcoma/primitive neuroectodermal tumor in oral and maxillofacial region].
He HW; Liu LK; Li YN; Wang D; He ZX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Sep; 40(5):379-82. PubMed ID: 16255919
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous Ewing's family sarcoma. Report of a case with immunostaining for glycoprotein p30/32 mic2.
Sexton CW; White WL
Am J Dermatopathol; 1996 Dec; 18(6):601-5. PubMed ID: 8989933
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
[TBL] [Abstract][Full Text] [Related]
19. [Cooperative Ewing's Sarcoma Studies 81/86: pathologico-anatomic and immunohistochemical findings and differential diagnosis of Ewing sarcoma].
Schmidt D; Harms D
Klin Padiatr; 1988; 200(3):236-42. PubMed ID: 3062261
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
Hartman KR; Triche TJ; Kinsella TJ; Miser JS
Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
